Health economics
Prevention Economics: Who Pays Upfront and Who Captures the Gains?
Prevention shifts costs and benefits across payers, providers, and patients in ways that rarely align in a single ledger.
2026-10-13 · Dr Vas editorial
The shift
Health systems have moved from reactive treatment of advanced disease toward earlier interventions that reduce incidence or delay progression. This change alters cash flows because prevention often requires sustained investment over years while acute care generates immediate claims. Payers that fund daily management rarely receive credit when downstream hospitalizations decline. Employers that sponsor wellness programs may see reduced absenteeism yet still face rising premiums driven by other enrollees. Hospitals lose revenue when admissions fall yet continue to carry fixed costs for capacity. The economic tension arises because accounting rules and contract terms treat prevention as an expense rather than a shared asset. Over time this produces underinvestment even when clinical evidence supports the approach. The shift therefore demands new payment designs that recognize multi-year horizons and distribute both outlays and returns across entities that currently operate in isolation.
How it works in clinic
In daily practice a primary-care team identifies elevated risk through routine labs and history then initiates counseling, medication, or referral to community programs. Each step consumes staff time and generates claims that the patient’s insurer must process. The clinic records these encounters as costs while the insurer records them as expenditures. When the intervention succeeds the avoided event appears years later in a different setting, often under a different payer. The original clinic receives no additional payment for the avoided admission and the original insurer may have lost the member to another plan. Workflow adjustments such as longer visits or care-coordinator time therefore remain unfunded unless a specific prevention contract exists. Clinicians must balance these unreimbursed efforts against productivity targets tied to visit volume. The result is selective uptake of prevention activities that fit existing fee schedules rather than those that produce the largest long-term system savings.
Who pays
Direct costs fall first on whichever entity covers the preventive service: government programs, commercial insurers, employers, or patients through copays. Indirect costs include clinician training, registry maintenance, and patient time away from work. Savings, when realized, appear as reduced spending on emergency care, specialist procedures, and long-term institutional stays. Those savings accrue to the payer responsible at the moment the event would have occurred, not necessarily the payer that funded the prevention. Self-insured employers may capture some gains through lower claims experience, yet stop-loss coverage and annual renewals blunt the effect. Public programs face the same mismatch when beneficiaries switch eligibility categories. Consequently the party writing the prevention check seldom sees a line-item credit for the downstream reduction. This separation of payment and benefit discourages voluntary expansion of prevention benefits beyond regulatory minimums.
Where it fails
Failure occurs when contract terms, eligibility churn, and accounting periods prevent recognition of multi-year returns. A commercial plan that invests in diabetes prevention may lose the member to Medicare before complications would have appeared. A hospital that reduces readmissions through better discharge planning sees its revenue drop without offsetting gain-sharing. Measurement systems that track only twelve-month medical loss ratios ignore later savings. Administrative friction adds further drag: prior authorization for preventive medications, narrow provider networks that exclude effective community programs, and lack of interoperable data across payers. These structural gaps turn clinically sound prevention into financial losses for the initiating organization even when total societal costs decline. Without explicit reconciliation mechanisms the market continues to underproduce prevention relative to its potential value.
United Kingdom NHS
The National Health Service operates under a single-payer structure that spans primary, secondary, and social care, allowing some internal capture of prevention gains. Integrated care boards can allocate funds to upstream services knowing that reduced hospital activity stays within the same overall budget envelope. Even here, however, annual spending rounds and separate capital budgets limit long-term planning. Primary-care networks receive incentive payments for prevention metrics yet must still meet acute-access targets that compete for the same workforce. When prevention succeeds, hospital trusts experience lower occupancy and must justify continued funding for unused beds. The single-payer advantage therefore reduces but does not eliminate the incentive misalignment. Cross-boundary issues persist when social-care savings from better prevention appear in local-authority ledgers rather than NHS accounts. The UK example illustrates that organizational integration helps yet still requires deliberate payment rules to translate clinical prevention into sustained financial support.
What to do this quarter
Map every prevention activity currently delivered against the payer that funds it and the payer that would have paid for the avoided event. Identify the three highest-volume services where these payers differ. Draft a one-page proposal for a shared-savings rider that assigns a portion of documented downstream reductions back to the prevention provider, using claims data already available. Meet with the two largest commercial plans and the state Medicaid agency to test interest in a twelve-month pilot limited to one clinical condition. Establish a simple tracking dashboard that records prevention encounters and links them to later utilization without creating new data-collection burdens. Schedule follow-up meetings before the next contract renewal cycle to embed the rider language. These steps convert the abstract economics of prevention into concrete contract adjustments that can be implemented within existing billing systems.
Three moves
- Align prevention payments with the entities that ultimately avoid the largest claims through multi-year reconciliation.
- Require quarterly reporting that attributes both costs and realized savings to the original prevention investment.
- Pilot shared-savings riders in the next renewal cycle for the three highest-impact services identified this quarter.
LetsGo.Health supplies the contract templates and attribution tools that make these moves operational.